Status:

COMPLETED

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Ovarian Cancer

Peritoneal Cancer

Eligibility:

FEMALE

65+ years

Brief Summary

Older woman with ovarian cancer have a worse prognosis compared to younger patients. However, the reason is not known. Currently, the standard of care is to evaluate younger and older patients with ca...

Eligibility Criteria

Inclusion

  • Patients must be \> or = to age of 65. Will receive platinum-based chemotherapy and surgery at MSKCC for stage II-IV ovarian, fallopian tube or peritoneal cancer.
  • Pathologic confirmation or high suspicion based on Ca125 level and/or radiologic evidence of ovarian, fallopian tube or peritoneal cancer.
  • Able to understand English.
  • Be able to provide informed consent.

Exclusion

  • Enrolled on a phase I trial.

Key Trial Info

Start Date :

November 8 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 17 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01471483

Start Date

November 8 2011

End Date

April 17 2025

Last Update

April 23 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Memorial Sloan-Kettering Cancer Center @ Suffolk

Commack, New York, United States, 11725

2

Memorial Sloan-Kettering Cancer Center at Commack

Commack, New York, United States, 11725

3

Memorial Sloan-Kettering Cancer Center

New York, New York, United States, 10065